MR contrast agents in hepatic cirrhosis and chronic hepatitis

Seminars in Ultrasound CT and MRI

Volumn 23, Issue 1, 2002, Pages 101-113

  Martí Bonmatí, Luis ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ARTERIAL BLOOD; CELL REGENERATION; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; HUMAN; INTERCELLULAR SPACE; LIVER CELL; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PARENCHYMA; LIVER REGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN BLOOD; PRIORITY JOURNAL; REVIEW;

EID: 0036174403     PISSN: 08872171     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-2171(02)90031-4     Document Type: Review

References (55)

1. Enlargement of hilar periportal space: A sign of early cirrhosis at MR imaging
2. Hepatic morphologic changes in cirrhosis: MR imaging findings
3. Hepatitis, cirrhosis, and hepatoma
4. Viral-induced cirrhosis: Grading of severity using MR imaging
5. Progressive viralinduced cirrhosis: Serial MR imaging findings and clinical correlation
6. Hepatic perfusion parameters in chronic liver disease: Dynamic CT measurements correlated with disease severity
7. Focal manifestations of diffuse liver disease at MR imaging
8. Functional images of hepatic perfusion obtained with dynamic CT
9. Chronic hepatitis: Correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience
10. Imaging of hepatic cirrhosis
11. MR imaging of cirrhotic nodules
12. Assessment of hepatic portal perfusion using T2 measurements of Gd-DTPA
13. MR imaging of the liver: Effect of portal hypertension on hepatic parenchymal enhancement using a gadolinium chelate
14. Confluent hepatic fibrosis in advanced cirrhosis: Evaluation with MR imaging
15. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: Prospective diagnosis with MR imaging and explantation correlation
16. Differentiation of healthy from cirrhotic livers: Evaluation of parametric images after contrast administration in MR imaging
17. MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers
18. Cirrhosis of the liver: MR imaging with Mangafodipir trisodium (MnDPDP)
19. Mn-DPDP enhanced MRI in experimental bile duct obstruction
20. Gadobenate dimeglumine a new contrast agent for MR imaging: Preliminary evaluation in healthy volunteers
21. Contrast-enhanced MR imaging of the liver: Comparison between GdBPTA and Mangafodipir
22. Gadobenate dimeglumine (BOPTA) enhanced MR imaging: Patterns of enhancement in normal liver and cirrhosis
23. Experimental hepatic dysfunction: Evaluation by MRI with Gd-EOB-DTPA
24. Definition of liver tumors in the presence of diffuse liver disease: Comparison of findings at MR imaging with positive and negative contrast agents
25. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequence
26. MR imaging enhancement with superparamagnetic iron oxide in chronic liver disease: Influence of liver dysfunction and parenchymal pathology
27. Signal changes in liver and spleen after Endorem administration in patients with and without liver cirrhosis
28. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide
29. Detection of hepatocellular carcinoma arising in cirrhotic livers: Comparison of gadolinium- and ferumoxides-enhanced MR imaging
30. Confluent hepatic fibrosis in cirrhosis: Ferumoxides-enhanced MR imaging findings
31. Liver tumors in cirrhosis: Experimental study with SPIO-enhanced MR imaging
32. Hepatocellular carcinoma in cirrhotic livers: Detection with unenhanced and iron oxide-enhanced MR imaging
33. Incidence and diagnostic features of macroregenerative nodules vs small hepatocellular carcinoma in cirrhotic livers
34. Macroregenerative nodules in a series of adult cirrhotic liver explants: Issues of classification and nomenclature
35. Hepatocellular carcinoma: Association with increased iron deposition in the cirrhotic liver at MR imaging
36. Dysplastic nodules and hepatocellular carcinoma: Thin-section MR imaging of explanted cirrhotic livers with pathologic correlation
37. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: Evaluation by CT during intraarterial injection of contrast medium
38. Small hepatocellular carcinoma: Relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma
39. An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinoma
40. Detection of hepatocellular carcinoma: Combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography
41. Small nodule detection in cirrhotic livers: Evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver
42. Small hepatocellular carcinoma in patients with chronic liver damage: Prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver
43. Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis
44. Small hepatocellular carcinoma: Differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPAenhanced MR imaging
45. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP)
46. Differentiation of hepatomas from nonhepatomatous masses: Use of MnDPDP-enhanced MR images
47. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions
48. Liver tumors: Comparison of MR imaging with Gd-EOB-DTPA and GdDTPA
49. Paradoxic uptake of Gd-EOB-DTPA by hepatocellular carcinoma in mice: Quantitative image analysis
50. Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: A comparative study by alternative free-response receiver operating characteristic analysis
51. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging
52. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions
53. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging
54. Preoperative detection of hepatocellular carcinoma: Ferumoxides-enhanced MR imaging versus combined helical CT during arterial portography and CT hepatic arteriography
55. Arterioportal shunts in cirrhotic patients: Evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide